| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXGN | Common Stock | Options Exercise | $106K | +20.9K | +49.73% | $5.04 | 63K | Jan 30, 2023 | Direct | |
| transaction | AXGN | Common Stock | Sale | -$137K | -14.1K | -22.38% | $9.69 | 48.9K | Jan 30, 2023 | Direct | F1, F2 |
| transaction | AXGN | Common Stock | Options Exercise | $106K | +20.9K | +42.79% | $5.04 | 69.9K | Jan 31, 2023 | Direct | |
| transaction | AXGN | Common Stock | Sale | -$137K | -14.3K | -20.49% | $9.55 | 55.6K | Jan 31, 2023 | Direct | F1, F3 |
| transaction | AXGN | Common Stock | Options Exercise | $106K | +20.9K | +37.69% | $5.04 | 76.5K | Feb 1, 2023 | Direct | |
| transaction | AXGN | Common Stock | Sale | -$136K | -14.6K | -19.02% | $9.36 | 61.9K | Feb 1, 2023 | Direct | F1, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXGN | Employee Stock Option (right to purchase) | Options Exercise | $0 | -20.9K | -33.33% | $0.00 | 41.9K | Jan 30, 2023 | Common Stock | 20.9K | $5.04 | Direct | F5 |
| transaction | AXGN | Employee Stock Option (right to purchase) | Options Exercise | $0 | -20.9K | -50% | $0.00 | 20.9K | Jan 31, 2023 | Common Stock | 20.9K | $5.04 | Direct | F5 |
| transaction | AXGN | Employee Stock Option (right to purchase) | Options Exercise | $0 | -20.9K | -100% | $0.00* | 0 | Feb 1, 2023 | Common Stock | 20.9K | $5.04 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, in order to exercise options that are scheduled to expire on March 1, 2023. |
| F2 | The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.95 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F3 | The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.36 to $9.77 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F4 | The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $9.20 to $9.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F5 | All shares of Common Stock underlying the employee stock option were fully vested on March 1, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on March 1, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter. |